Events

Recall of U-100 Insulin Syringe 0.5mL 27G and 29G

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Terumo Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2018-RN-00171-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2018-02-23
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2018-RN-00171-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Taechang industrial is initiating a recall of all lot numbers of terumo branded u-100 insulin syringe with a capacity of 0.5ml x 27g and 29g due to incorrect information contained on the device peel pack.The statement:"0.5ml single use syringe for 100 units or less in two unit increments"is incorrect and should state:"0.5ml single use syringe for 50 units or less in one unit increments"in essence, the 0.5ml peel packs have been inadvertently printed with information intended for the 1.0ml peel pack. the printing on the syringes themselves is correct.
  • Action
    Terumo is requesting customers: 1. Review the supplied urgent medical device recall (permanent removal) notification, inspect all stock on hand and quarantine affected lot numbers prior to return as per the instructions given in the customer letter. Ensure all relevant staff are made aware of this recall; 2.If any of the recalled product could have been transferred from your facility to another, please immediately notify that facility know of this recall; 3.Where possible, return all affected stock to your supply department for consolidated return to Terumo Australia as per the instructions given; and 4.Terumo will be providing credit for all returned stock. Replacement stock will not be automatically issued. Please process a new order if more stock is required.

Device

U-100 Insulin Syringe 0.5mL 27G and 29G
  • Model / Serial
    U-100 Insulin Syringe 0.5mL 27G and 29G Lot Numbers for product SS*05M2713KA: 7D700, 7E700, 7F731, 7G719, 7I701, 6H713,6K700 Lot Numbers for product SS*05M2913KA : 7A713, 7G720, 7I7012, 7A713, 7B728, 6F700, 6F706Multiple Lot Numbers (see attached)ARTG: 234082 (Terumo Australia Pty Ltd - Insulin syringe, fixed-needle)
  • Manufacturer
    Terumo Australia Pty Ltd

Manufacturer

Terumo Australia Pty Ltd